1. Market Research
  2. > Business Services
  3. > Research and Development Market Trends
  4. > Research and Development Analysis & Statistics 2020 - United States (p3)

Research and Development Analysis & Statistics 2020 - United States (p3)

61-90 of about 300 reports

Genital Herpes - Pipeline Review, H2 2019

  • $ 2000
  • November 2019
  • 98 pages

Genital Herpes - Pipeline Review, H2 2019 Summary Pharmaceutical and Healthcare disease pipeline guide Genital Herpes - Pipeline Review, H2 2019, provides an overview of the Genital Herpes (Infectious ...

  • Research And Development
  • Vaccine
  • United States
  • Product Initiative
  • Starpharma Holdings Limited

Integrin Beta 3 - Pipeline Review, H2 2019

  • $ 3500
  • August 2019
  • 74 pages

Integrin Beta 3 - Pipeline Review, H2 2019 Summary Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) pipeline Target constitutes close to 24 molecules. Out of which approximately ...

  • Hospital
  • Research And Development
  • United States
  • Product Initiative
  • SciFluor Life Sciences, LLC

P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Pipeline Review, H2 2019

  • $ 3500
  • August 2019
  • 50 pages

P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Pipeline Review, H2 2019 Summary P2X Purinoceptor 7 (P2Z Receptor or P2RX7) pipeline Target constitutes close to 16 molecules. The latest report P2X Purinocepto ...

  • Research And Development
  • Therapy
  • United States
  • Product Initiative
  • Biosceptre International Limited

Life Science Analytics Market by Type, Application, Component, Delivery, End User - Global Forecast to 2024

  • $ 4950
  • July 2019
  • 167 pages

Technological advancements, the need for improved data standardization, and the growing adoption of analytics solutions in clinical trials are the key factors driving the life science analytics market. The ...

  • Research And Development
  • North America
  • United States
  • Forecast
  • Wipro Limited

Sepsis - Pipeline Review, H1 2019

  • $ 2000
  • April 2019
  • 320 pages

Sepsis - Pipeline Review, H1 2019 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Sepsis - Pipeline Review, H1 2019, provides an overview of the Sepsis (Infectious ...

  • Blood Disease
  • Cell Therapy
  • Research And Development
  • United States
  • Bristol-Myers Squibb Company

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Pipeline Review, H1 2019

  • $ 3500
  • April 2019
  • 75 pages

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Pipeline Review, H1 2019 Summary Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Integrin beta-3 (?3) ...

  • Research And Development
  • Therapy
  • United States
  • Product Initiative
  • SciFluor Life Sciences, LLC

CornerStone Research & Development Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 16 pages

Summary CornerStone Research & Development Inc (Capstone Nutrition), doing business as Capstone Nutrition Inc is a developer and manufacturer of nutrition products.The company offers development, production ...

  • Healthcare
  • Research And Development
  • United States
  • Company Operations

Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Pipeline Review, H2 2018

  • $ 3500
  • November 2018
  • 111 pages

Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Pipeline Review, H2 2018 Summary Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase ...

  • Research And Development
  • Therapy
  • United States
  • Product Initiative
  • Pfizer Inc.

Momenta Pharmaceuticals Inc (MNTA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 56 pages

Summary Momenta Pharmaceuticals Inc (Momenta) is a biotechnology company which specializes in the structural analysis, characterization, and design of complex pharmaceuticals.The company’s products include ...

  • Pharmaceutical
  • Research And Development
  • United States
  • Company
  • Momenta

Cytokinetics Inc (CYTK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 61 pages

Summary Cytokinetics Inc (Cytokinetics) is a late stage biopharmaceutical company, which discovers, develops, and commercializes muscle activators for the treatment of diseases associated with reduced ...

  • Clinical Trial
  • Pharmaceutical
  • Research And Development
  • United States
  • Cytokinetics, Inc.

Codexis Inc (CDXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 46 pages

Summary Codexis Inc (Codexis) is a protein engineering company, which develops proteins for a wide range of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, industrial ...

  • Pharmaceutical
  • Research And Development
  • United States
  • Demand
  • Codexis, Inc.

Flex Pharma Inc (FLKS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 40 pages

Summary Flex Pharma Inc (Flex Pharma) is a clinical-stage biotechnology company that offers discovery and development of innovative and proprietary treatments for muscle cramps, spasms and spasticity connected ...

  • Pharmaceutical
  • Research And Development
  • United States
  • Company
  • Flex Pharma, Inc.

Research and Development in the USA

  • $ 660
  • November 2018
  • 5 pages

Euromonitor International’s Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to the size and shape of the Research and Development ...

  • Research And Development
  • United States
  • Company Operations
  • Market Structure
  • Trade

Cellectis SA (ALCLS) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 47 pages

Summary Cellectis SA (Cellectis) is a clinical-stage biopharmaceutical company that research, develop and commercialise rational genome engineering technologies.The company pioneers gene editing company, ...

  • Immunotherapy
  • Research And Development
  • United States
  • Company Financials
  • Cellectis S.A.

Indoleamine 2,3 Dioxygenase 1 (Indoleamine Pyrrole 2,3 Dioxygenase 1 or IDO1 or EC 1.13.11.52) - Pipeline Review, H2 2018

  • $ 3500
  • October 2018
  • 118 pages

Indoleamine 2,3 Dioxygenase 1 (Indoleamine Pyrrole 2,3 Dioxygenase 1 or IDO1 or EC 1.13.11.52) - Pipeline Review, H2 2018 Summary Indoleamine 2,3 Dioxygenase 1 (Indoleamine Pyrrole 2,3 Dioxygenase 1 o ...

  • Cancer
  • Research And Development
  • Therapy
  • United States
  • Product Initiative

Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline Review, H2 2018

  • $ 3500
  • October 2018
  • 92 pages

Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline ...

  • Cancer
  • Research And Development
  • United States
  • Product Initiative
  • Oryzon Genomics S.A.

Tumor Necrosis Factor Receptor Superfamily Member 9 (4-1BB Ligand Receptor or T Cell Antigen 4-1BB Homolog or T Cell Antigen ILA or CD137 or TNFRSF9) - Pipeline Review, H2 2018

  • $ 3500
  • October 2018
  • 109 pages

Tumor Necrosis Factor Receptor Superfamily Member 9 (4-1BB Ligand Receptor or T Cell Antigen 4-1BB Homolog or T Cell Antigen ILA or CD137 or TNFRSF9) - Pipeline Review, H2 2018 Summary Tumor Necrosis ...

  • Immunotherapy
  • Research And Development
  • Therapy
  • United States
  • Juno Therapeutics Inc.

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Pipeline Review, H2 2018

  • $ 3500
  • October 2018
  • 53 pages

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Pipeline Review, H2 2018 Summary Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide ...

  • Research And Development
  • Therapy
  • United States
  • Product Initiative
  • Amylin Pharmaceuticals, Inc.

Aevi Genomic Medicine Inc (GNMX) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 27 pages

Summary Aevi Genomic Medicine Inc (Aevi), formerly Medgenics Inc is a research and development company that discovers and develops novel therapies for pediatric onset and life-altering diseases.The company ...

  • Medical Device
  • Medical Supply
  • Research And Development
  • United States
  • Company

Corium International Inc (CORI) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 33 pages

Summary Corium International Inc (Corium) is a commercial-stage biopharmaceutical company that produces and develops central nervous system pharmaceutical products.The company develops transdermal healthcare ...

  • Medical Device
  • Research And Development
  • United States
  • Company Operations
  • Corium International, Inc.

IQVIA Holdings Inc (IQV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 65 pages

Summary IQVIA Holdings Inc (IQVIA), formerly Quintiles IMS Holdings, Inc, is a provider of information, novel technological solutions and contract research services, by harnessing data and science, to ...

  • Healthcare
  • Pharmaceutical
  • Research And Development
  • United States

Aevi Genomic Medicine Inc (GNMX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 52 pages

Summary Aevi Genomic Medicine Inc (Aevi), formerly Medgenics Inc is a research and development company that discovers and develops novel therapies for pediatric onset and life-altering diseases.The company ...

  • Healthcare
  • Research And Development
  • United States
  • Company
  • Medgenics, Inc.

Dyadic International Inc (DYAI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 37 pages

Summary Dyadic International Inc (Dyadic) is a biotechnology company that develops, discovers, manufactures, and commercializes protein-based drugs.The company utilizes its patented and proprietary technology ...

  • Pharmaceutical
  • Research And Development
  • United States
  • Company Operations
  • Mitsubishi Corporation

Corium International Inc (CORI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 33 pages

Summary Corium International Inc (Corium) is a commercial-stage biopharmaceutical company that produces and develops central nervous system pharmaceutical products.The company develops transdermal healthcare ...

  • Pharmaceutical
  • Research And Development
  • United States
  • Company Operations
  • Corium International, Inc.

Janssen Research & Development LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • September 2018
  • 41 pages

Summary Janssen Research & Development LLC (Janssen), formerly Johnson & Johnson Pharmaceutical Research & Development LLC, a subsidiary of Johnson & Johnson, is a pharmaceutical company that offers research ...

  • Pharmaceutical
  • Research And Development
  • United States
  • Company Operations
  • Janssen Biotech, Inc.

Ebola virus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H2 2018

  • $ 2000
  • September 2018
  • 276 pages

Ebola virus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Ebola virus Infections (Ebola ...

  • Monoclonal Antibody
  • Research And Development
  • United States
  • Product Initiative
  • Hemispherx Biopharma, Inc.

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H2 2018

  • $ 3500
  • September 2018
  • 121 pages

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H2 2018 Summary Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 ...

  • Cancer
  • Research And Development
  • Therapy
  • United States
  • Product Initiative

Orexin Receptor Type 1 (Hypocretin Receptor Type 1 or HCRTR1) - Pipeline Review, H2 2018

  • $ 3500
  • September 2018
  • 67 pages

Orexin Receptor Type 1 (Hypocretin Receptor Type 1 or HCRTR1) - Pipeline Review, H2 2018 Summary Orexin Receptor Type 1 (Hypocretin Receptor Type 1 or HCRTR1) pipeline Target constitutes close to 14 molecules. ...

  • Pharmaceutical
  • Research And Development
  • United States
  • Product Initiative
  • Eisai Co., Ltd.

Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Pipeline Review, H2 2018

  • $ 3500
  • September 2018
  • 83 pages

Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Pipeline Review, H2 2018 Summary Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide ...

  • Research And Development
  • United States
  • Company
  • Company Operations
  • Product Initiative

Corium International Inc (CORI) - Product Pipeline Analysis, 2018 Update

  • $ 750
  • August 2018
  • 37 pages

Summary Corium International Inc (Corium) is a commercial-stage biopharmaceutical company that produces and develops central nervous system pharmaceutical products.The company develops transdermal healthcare ...

  • Antipsychotic
  • Research And Development
  • United States
  • Company Operations
  • Corium International, Inc.

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on